NCT02188095 is a clinical trial in Hip Arthritis, sponsored by Aesculap AG.

Who is sponsoring NCT02188095?

NCT02188095 is sponsored by Aesculap AG.

What condition does NCT02188095 study?

NCT02188095 studies Hip Arthritis.

Is NCT02188095 still recruiting?

NCT02188095 is currently completed. Last updated 2 March 2026.

Last reviewed 2026-03-02 · How we verify

NCT02188095

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Post Market Clinical Follow-Up Study of Excia T® Hip Prosthesis

Completed Last updated 2 March 2026

What this trial tests

trial in Hip Arthritis in 100 participants. Completed in 7 November 2025.

Timeline

3 September 2014

Primary endpoint
6 October 2015

7 November 2025

Quick facts

Lead sponsor	Aesculap AG
Status	Completed
Study type	OBSERVATIONAL
Enrollment	100
Start date	3 September 2014
Primary completion	6 October 2015
Estimated completion	7 November 2025
Sites	2 locations across Germany

Conditions studied

Hip Arthritis — all drugs for Hip Arthritis →

Sponsor

Aesculap AG — full company profile →

Who can join

18 and older, any sex, with Hip Arthritis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Clinical and radiological 10 year results of Excia T® Hip Stem

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Hip Arthritis

Currently open trials in the same condition.

NCT06603831 — Clinical Evaluation and Cost-effectiveness Analysis of 3D Digital Surgery in Traumatology · NA · recruiting
NCT05543941 — Evaluating XPERIENCE™ Advanced Surgical Irrigation · NA · recruiting
NCT04544904 — The Technology, Exercise Programming, and Activity Prescription for Enhanced Mobility (TEAM) Study · NA · active not recruiting
NCT04995822 — Post Market Clinical Follow-up of EUROSTEM Femoral Stem · active not recruiting
NCT04700969 — Onset PrevenTIon of Urinary Retention in Orthopaedic Nursing and Rehabilitation · NA · active not recruiting

Other Aesculap AG trials

Trials by the same sponsor.

NCT05441618 — Post Market Clinical Follow-Up Study on the Performance and Safety of Lyoplant® · completed
NCT06298500 — Clinical Performance of HISTOACRYL® LAPFIX - CANNULA for Laparoscopic Inguinal Hernia Repair · completed
NCT05944081 — Postmarket Clinical Follow-Up Study on Arcadius XP L® Interbody Fusion Device · withdrawn
NCT06055946 — Symmcora® Long-term Bidirectional Barbed Suture for Anastomosis in Patients Undergoing Robot Assisted Radical Prostatect · completed
NCT05182320 — Study Measuring the Effects of Patient Data for Total Hip and Total Knee Arthroplasty Patients Using an APP Based Sensor · withdrawn

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02188095 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Aesculap AG
Last refreshed: 2 March 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02188095.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing